Immunoadjuvant Therapy and Noninvasive Ventilation for Acute Respiratory Failure in Lung Tuberculosis: A Case Study.

Case Rep Pulmonol

Servicios de Salud de Chihuahua, Sistema Estatal de Salud, Calle Tercera No. 604, Piso 3 Colonia Centro, 31000 Chihuahua, CHIH, Mexico.

Published: August 2015

Acute respiratory failure caused by pulmonary tuberculosis is a rare event but with a high mortality even while receiving mechanical ventilatory support. We report the case of a young man with severe pulmonary tuberculosis refractory to conventional therapy who successfully overcame the critical period of his condition using noninvasive ventilation and immunoadjuvant therapy that included three doses of etanercept 25 mg subcutaneously. We conclude that the use of etanercept along with antituberculosis treatment appears to be safe and effective in patients with pulmonary tuberculosis presenting with acute respiratory failure.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530232PMC
http://dx.doi.org/10.1155/2015/283867DOI Listing

Publication Analysis

Top Keywords

acute respiratory
12
respiratory failure
12
pulmonary tuberculosis
12
immunoadjuvant therapy
8
noninvasive ventilation
8
therapy noninvasive
4
ventilation acute
4
failure lung
4
tuberculosis
4
lung tuberculosis
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!